Sunday, March 17, 2019

Another 43 lots of medication used to treat high blood pressure, congestive heart failure recalled

By Kevin Foster | March 16, 2019 at 6:45 PM CDT - Updated March 17 at 11:07 AM

Legacy Pharmaceutical Packaging is voluntarily recalling 43 lots of medication used to treat high blood pressure and congestive heart failure. The news is the latest in a series of medication recalls announced by the U.S. Food and Drug Administration (FDA) initiated due to the potential presence of cancer causing impurities.

In two different recalls announced Friday Mar. 15, the company said it’s falling in line with two other pharmaceutical companies, Camber Pharmaceuticals and Torrent Pharmaceuticals, which recalled medications after detecting trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA). The tablets were made by Hetero Labs Limited.

NMBA is the second potential threat to result in a recall. The other potential threat, NDEA, led to several recalls of losartan, valsartan and irbesartan.


No comments:

Post a Comment